These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 28875682)
21. Hydroxyethyl starch conjugates for improving the stability, pharmacokinetic behavior and antitumor activity of 10-hydroxy camptothecin. Li G; Li Y; Tang Y; Zhang Y; Zhang Y; Yin T; Xu H; Cai C; Tang X Int J Pharm; 2014 Aug; 471(1-2):234-44. PubMed ID: 24861941 [TBL] [Abstract][Full Text] [Related]
22. [Distribution of hydroxycamptothecin after aerosol inhalation in rabbits]. Chen J; Fang Y; Zhang HX; Huang LL; Qian XP; Liu BR Yao Xue Xue Bao; 2004 Sep; 39(9):747-51. PubMed ID: 15606028 [TBL] [Abstract][Full Text] [Related]
23. A pH-responsive prodrug delivery system of 10-HCPT for controlled release and tumor targeting. Liu Y; Li D; Guo X; Xu H; Li Z; Zhang Y; Song C; Fan R; Tang X; Zhang Z Int J Nanomedicine; 2017; 12():2227-2242. PubMed ID: 28356739 [TBL] [Abstract][Full Text] [Related]
24. PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effects against lung cancer. Zhang X; Gan Y; Gan L; Nie S; Pan W J Pharm Pharmacol; 2008 Aug; 60(8):1077-87. PubMed ID: 18644200 [TBL] [Abstract][Full Text] [Related]
25. Enhanced liver-targeting via coadministration of 10-Hydroxycamptothecin polymeric micelles with vinegar baked Radix Bupleuri. Wu H; Yu T; Tian Y; Wang Y; Zhao R; Mao S Phytomedicine; 2018 May; 44():1-8. PubMed ID: 29895488 [TBL] [Abstract][Full Text] [Related]
26. A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: in vitro and in vivo evaluation. Yang X; Liu Y; Zhao Y; Han M; Guo Y; Kuang H; Wang X Int J Nanomedicine; 2016; 11():2979-94. PubMed ID: 27382284 [TBL] [Abstract][Full Text] [Related]
27. A two-step pH-dependent liquid-liquid extraction combined with HPLC-fluorescence method for the determination of 10-hydroxycamptothecin in mouse liver tissue. Zheng J; Guo H; Guo N; Ma W; Jing L; Zhang R; Dai Z; Yan X; Wang Y; Wang Z Pharm Biol; 2012 Aug; 50(8):954-61. PubMed ID: 22486519 [TBL] [Abstract][Full Text] [Related]
28. Monolithic osmotic tablet containing solid dispersion of 10-hydroxycamptothecin. Chen H; Jiang G; Ding F Drug Dev Ind Pharm; 2009 Feb; 35(2):131-7. PubMed ID: 19169941 [TBL] [Abstract][Full Text] [Related]
29. Enhanced tumor targeting and antitumor efficacy via hydroxycamptothecin-encapsulated folate-modified N-succinyl-N'-octyl chitosan micelles. Zhu H; Cao J; Cui S; Qian Z; Gu Y J Pharm Sci; 2013 Apr; 102(4):1318-32. PubMed ID: 23400693 [TBL] [Abstract][Full Text] [Related]
30. Release modulation and cytotoxicity of hydroxycamptothecin-loaded electrospun fibers with 2-hydroxypropyl-beta-cyclodextrin inoculations. Xie C; Li X; Luo X; Yang Y; Cui W; Zou J; Zhou S Int J Pharm; 2010 May; 391(1-2):55-64. PubMed ID: 20170717 [TBL] [Abstract][Full Text] [Related]
31. [Preparation and in vitro drug release study of long-circulating hydroxycamptothecin nanoparticles]. Xi N; Hou LB Zhong Yao Cai; 2010 Apr; 33(4):610-3. PubMed ID: 20845792 [TBL] [Abstract][Full Text] [Related]
32. [Pharmacokinetic study of intraperitoneal chemotherapy with HCPT]. Ye M; Lin XX; Pan HM; Li N; Lou F; Jin W; Zheng Y; Wu JM Zhongguo Zhong Yao Za Zhi; 2005 Oct; 30(20):1610-2. PubMed ID: 16422545 [TBL] [Abstract][Full Text] [Related]
33. Hydroxycamptothecin liposomes based on thermal and magnetic dual-responsive system: preparation, in vitro and in vivo antitumor activity, microdialysis-based tumor pharmacokinetics. Zhu HM; Gu JH; Xie Y; Xie B; Ling JJ J Drug Target; 2018 Apr; 26(4):345-356. PubMed ID: 28920483 [TBL] [Abstract][Full Text] [Related]
34. [Antitumor effects of ring-closed and ring-opened hydroxycamptothecin on oral squamous carcinoma cell line Tca8113]. Wang AX; Li S; Ding XQ; Chen Y; Chen D Ai Zheng; 2005 Aug; 24(8):970-4. PubMed ID: 16086875 [TBL] [Abstract][Full Text] [Related]
35. Development of a chemically stable 10-hydroxycamptothecin nanosuspensions. Pu X; Sun J; Wang Y; Wang Y; Liu X; Zhang P; Tang X; Pan W; Han J; He Z Int J Pharm; 2009 Sep; 379(1):167-73. PubMed ID: 19505545 [TBL] [Abstract][Full Text] [Related]
36. Intracellular delivery of 10-hydroxycamptothecin with targeted nanostructured lipid carriers against multidrug resistance. Liu M; Chen D; Mukerabigwi JF; Chen S; Zhang Y; Lei S; Luo S; Wen Z; Cao Y; Huang X; He H J Drug Target; 2016; 24(5):433-40. PubMed ID: 26422582 [TBL] [Abstract][Full Text] [Related]
37. [Study on pharmacokinetics of HCPT nanosuspensions with ability of inhibiting P-gp in rats after oral administration]. Pu X; Sun J; Zhang P; Wang Y; Sun Y; He Z Zhongguo Zhong Yao Za Zhi; 2011 Jul; 36(14):1959-63. PubMed ID: 22016968 [TBL] [Abstract][Full Text] [Related]
38. Development of quercetin-phospholipid complex to improve the bioavailability and protection effects against carbon tetrachloride-induced hepatotoxicity in SD rats. Zhang K; Zhang M; Liu Z; Zhang Y; Gu L; Hu G; Chen X; Jia J Fitoterapia; 2016 Sep; 113():102-9. PubMed ID: 27431774 [TBL] [Abstract][Full Text] [Related]
39. Preparation, characterization, biodistribution and antitumor efficacy of hydroxycamptothecin nanosuspensions. Han M; Liu X; Guo Y; Wang Y; Wang X Int J Pharm; 2013 Oct; 455(1-2):85-92. PubMed ID: 23928147 [TBL] [Abstract][Full Text] [Related]
40. [Preparation of 10-hydroxycamptothecin semisolid lipid nanoparticles and investigation of its stability]. Xi N; Hou LB; Yan XQ; Jiang QF; Wang CX Zhong Yao Cai; 2006 Jan; 29(1):63-6. PubMed ID: 16722323 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]